The
US food and drug regulatory body has allowed emergency use of an
investigational anti-viral vaccine to treat COVID-19 patients after some
researches, including one led by an Indian-American physician, found that the
drug helped recover some of the infected cases faster.
The
Food and Drug Administration gave emergency use authorization for the use of
investigational anti-viral Remdesivir in the treatment of COVID-19 patients.
The
FDA authorisation came after researches, including one led by Indian-American
physician Aruna Subramanian, reported Remdesivir shortened the recovery times
in people who have fallen ill from the new coronavirus.
"I'm
pleased to announce that Gilead now has an emergency use authorization from the
FDA for Remdesivir," US President Donald Trump told reporters at the White
House on Friday.
Trump
said that EUA is an important treatment for hospitalized coronavirus patients.
Health
and Human Services Secretary Alex Azar said that this is a significant step
forward in battling COVID-19.
Tags
Medicine